Routine, scalable production processes that deliver stable molecules at high yields with simple purification and with ease of formulation

Although many bi- or multi-specific antibody platforms have been described in the literature, most of these have faced intractable manufacturing challenges when considered for large scale production. Elstar’s proprietary UniTI™ technology overcomes these challenges as it generates molecules that deliver higher yields, stable molecules, simpler purification, and ease of formulation. The manufacturing of Elstar’s multi-functional molecules therefore employs scalable industry manufacturing purification processes and delivers yields and purity seen with simple monoclonal antibodies.

blue flow chart showing manufacturing process